The 5 Dumbest Thing...
Health Care: Drugs
Infinity Pharmaceuticals Inc. (INFI: NASDAQ)
$6.36 -0.04 | -0.62%
02/10/12 - 11:55 AM ET
29.51K / 62.10K
Vol / Avg. Vol:6.29 / 6.40
Open / Prev. Close:6.12 - 6.44
Today's Range:5.23 - 10.42
52 Wk Range:-27.49%
Performance YTD:TheStreet Rating:
Portfolios with INFI
- Portfolio NameUser Type
- Contributor8 Health Care Stocks With R...
- UserASCO 2010
- UserPART 7 JPMorgan 28th Annual...
- UserASCO 2009 Nymph's Watch List.
- UserPART 6 JPMorgan 27th Annual...
- UserPART 7 JPMorgan 26th Annual...
- UserBENITRANS EA
- Userneelkevin Portfolio 1
- UserLougen Portfolio 1
- Userconyco
Latest INFI Headlines from TheStreet
- Infinity Stock Gaps Down On Today's Open (INFI) 01.27.12 | 08:01 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- Infinity To Present New Preclinical Data On IPI-926, A Novel Smoothened Antagonist Targeting The Hedgehog Pathway, At Upcoming AACR Meeting 03.23.11 | 08:03 am
- Infinity Provides Company Update And Reports Fourth Quarter And Full-Year 2010 Financial Results 03.15.11 | 04:03 pm
- Infinity Announces The Date Of Its Fourth Quarter 2010 Financial Results Conference Call And Webcast 03.08.11 | 08:03 am
- Infinity Initiates Phase 2 Trial Of IPI-926 In Patients With Chondrosarcoma 03.03.11 | 08:03 am
- Infinity Pharmaceuticals To Present At Two Upcoming Conferences 02.28.11 | 08:02 am
- Infinity Initiates Phase 2 Portion Of Trial Of IPI-926 In Pancreatic Cancer 02.22.11 | 08:02 am
- Infinity Provides 2011 Goals And Guidance 01.07.11 | 08:01 am
- Infinity Pharmaceuticals To Present At 29th Annual J.P. Morgan Healthcare Conference 01.05.11 | 08:01 am
Press Releases for INFI
- Infinity Pharmaceuticals Announces Its Participation At Three Investor Conferences - Business Wire 02.06.12 | 08:02 am
- Infinity Reports Update From Phase 2 Study Of Saridegib Plus Gemcitabine In Patients With Metastatic Pancreatic Cancer - Business Wire 01.27.12 | 06:01 am
- Infinity Reports New Data From Phase 1b Trial Of Saridegib In Patients With Pancreatic Cancer At ASCO-GI - Business Wire 01.20.12 | 02:01 pm
- Infinity Pharmaceuticals, Inc. To Present At 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 08:01 am
- Infinity Provides Key 2012 Goals And Financial Guidance - Business Wire 01.04.12 | 08:01 am
- Infinity And Mundipharma Extend Global Strategic Alliance - Business Wire 11.29.11 | 06:11 am
- Infinity Reports Third Quarter 2011 Financial Results - Business Wire 11.08.11 | 04:11 pm
- Infinity Pharmaceuticals To Present At Piper Jaffray Health Care Conference - Business Wire 11.07.11 | 08:11 am
- Infinity Announces The Date Of Its Third Quarter 2011 Financial Results Conference Call And Webcast - Business Wire 10.27.11 | 08:10 am
- Infinity Pharmaceuticals Announces Its Participation At Two Investor Conferences - Business Wire 10.26.11 | 08:10 am
Partner Headlines for INFI
- Company News for January 30, 2012 - Corporate Summary - Zacks 01.30.12 | 10:01 am
- Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer - Seeking Alpha 10.25.11 | 08:10 am
- Company News for May 10, 2011 - Corporate Summary - Zacks 05.10.11 | 10:05 am
- Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker - SeekingAlpha.com 04.14.10 | 04:04 am
